[an error occurred while processing this directive]
Review

Epigenetic regulation and related diseases during placental development

Expand
  • 1. Renmin Hospital of Wuhan University, Wuhan 430060, China
    2. Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China
    3. Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China

Received date: 2016-11-13

  Revised date: 2017-02-23

  Online published: 2017-02-27

Supported by

the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(30830112);The Key Program of National Natural Science Foundation of China(81430089)

Abstract

The placenta is vital to fetal growth and development, as it bridges the fetus and the mother. Genome-wide epigenetic regulations (e.g., DNA methylation, histone modifications, non-coding RNAs) participate in many aspects of placenta development, including decidua of the uterus, trophoblast cell adhesion and invasion, angiogenesis and placental imprinted gene expression. Environmental factors during pregnancy, such as heavy metals, chemical compounds, modern assisted reproductive technology and the nutrient conditions, may cause abnormal placental epigenetics. Furthermore, sex differential expression of placental genes also contributes to epigenetic modifications. As prenatal DNA methylation analysis can detect abnormal epigenetic modifications, it is a potential diagnosis tool for early stage diseases and may help disease intervention and treatment. Here, we review not only regulations of epigenetic modifications during development of the placenta, but also the influences of environmental factors. The potential value for diagnosis and treatment is also discussed.

Cite this article

Fulin Liu, Jin Zhou, Wei Zhang, Hui Wang, . Epigenetic regulation and related diseases during placental development[J]. Hereditas(Beijing), 2017 , 39(4) : 263 -275 . DOI: 10.16288/j.yczz.16-380

References

[1] Vaiman D. Genes, epigenetics and miRNA regulation in the placenta. Placenta, 2016, doi: 10.1016/j.placenta. 2016.12.026.
[2] Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science, 1999, 286(5439): 481-486.
[3] Novakovic B, Saffery R. The ever growing complexity of placental epigenetics-role in adverse pregnancy outcomes and fetal programming. Placenta, 2012, 33(12): 959-970.
[4] Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science, 2001, 293(5532): 1089-1093.
[5] Apostolidou S, Abu-Amero S, O'Donoghue K, Frost J, Olafsdottir O, Chavele KM, Whittaker JC, Loughna P, Stanier P, Moore GE. Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight. J Mol Med, 2007, 85(4): 379-387.
[6] Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: A meta-analysis. Obstet Gynecol, 2004, 103(3): 551-563.
[7] Diplas AI, Lambertini L, Lee MJ, Sperling R, Lee YL, Wetmur JG, Chen J. Differential expression of imprinted genes in normal and IUGR human placentas. Epigenetics, 2009, 4(4): 235-240.
[8] Chandrasekharan MB, Huang F, Chen YC, Sun ZW. Histone H2B C-terminal helix mediates trans-histone H3K4 methylation independent of H2B ubiquitination. Mol Cell Biol, 2010, 30(13): 3216-3232.
[9] Holt MT, David Y, Pollock S, Tang ZY, Jeon J, Kim J, Roeder RG, Muir TW. Identification of a functional hotspot on ubiquitin required for stimulation of methyltransferase activity on chromatin. Proc Natl Acad Sci USA, 2015, 112(33): 10365-10370.
[10] Bird A. DNA methylation patterns and epigenetic memory. Genes Dev, 2002, 16(1): 6-21.
[11] Lehnertz B, Ueda Y, Derijck AAHA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen TP, Li E, Jenuwein T, Peters AHFM. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol, 2003, 13(14): 1192-1200.
[12] Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature, 2007, 445(7124): 214-218.
[13] Niessen HEC, Demmers JA, Voncken JW. Talking to chromatin: post-translational modulation of polycomb group function. Epigenetics Chromatin, 2009, 2: 10.
[14] Donker RB, Mouillet JF, Nelson DM, Sadovsky Y. The expression of argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Mol Hum Reprod, 2007, 13(4): 273-279.
[15] Terranova R, Yokobayashi S, Stadler MB, Otte
Outlines

/